Neoadjuvant low-dose radiotherapy plus durvalumab and chemotherapy for potentially resectable stage III NSCLC: A phase Ib dose-escalation study
Article in Radiotherapy and Oncology (April 2024)
The most recent citing publications are shown below. View all 317 publications that cite this research output on Dimensions.
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients
Article in Clinical and Translational Medicine (April 2024)
Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature
Article in American Journal of Case Reports (April 2024)